Lenacapavir for Individuals Adherent to Daily Oral PrEP
This Viewpoint discusses the potential advantages of injectable preexposure prophylaxis (PrEP) drugs such as lenacapavir for persons unable to adhere to daily oral HIV PrEP and highlights ways in which lenacapavir and expanded PrEP options could offer tailored and effective ways to better meet the diverse needs of at-risk individuals. Source link
Patient Information: Genital Herpes
This JAMA Patient Page describes genital herpes and its symptoms, diagnosis, treatment, and prevention measures. Source link
The Urgent Case for Recommitting to Global HIV/AIDS Goals
This Viewpoint discusses the need to recommit to the fight against HIV/AIDS to reach the United Nation’s 2030 goal of ending the epidemic as a public health threat. Source link
Optimizing the National Response to the Syphilis and Congenital Syphilis Syndemic
This Viewpoint discusses the rising rates of syphilis cases in the US and how the federal government is leading a coordinated response to address this resurgence involving enhancing testing, treatment, and education. Source link
Point-of-Care Testing to Combat Congenital Syphilis—The Time Is Now
This Viewpoint highlights the importance of point-of-care tests to detect syphilis, leading to timely treatment of syphilis and reducing complications including congenital syphilis. Source link
Treatment of Buschke-Löwenstein Tumor With Radiotherapy and Cemiplimab
This case report describes a woman in her late 60s with progressive enlarged painful groin masses spreading from the labia to the perianal area, bleeding, and weight loss. Source link
Recent Incarceration and HIV Risk Among Women Who Use Heroin
This cross-sectional study examines associations between incarceration and adverse HIV-related and drug use-related outcomes among women who used heroin in Tanzania. Source link
New Global Tuberculosis Cases Hit Record High
Tuberculosis (TB) is once again the leading global cause of death from infectious disease, surpassing COVID-19. In 2023, about 8.2 million people were newly diagnosed with TB, the highest number recorded since the World Health Organization (WHO) began monitoring the disease in 1995. Source link
Bacterial STIs and Doxycycline Postexposure Prophylaxis Among Individuals Using HIV PrEP
This cohort study evaluates the early uptake of doxycycline postexposure prophylaxis (doxyPEP) and changes in sexually transmitted infection incidence following doxyPEP initiation. Source link
Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends
This study assesses the association of citywide doxycycline postexposure prophylaxis guideline release with reported chlamydia, gonorrhea, and early syphilis cases in men who have sex with men and in transgender women in San Francisco, California. Source link
